Voglibose Tablets bulk supplier for pharma manufacturers

Voglibose Tablets 0.2 mg, 0.3 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 0.2 mg, 0.3 mg

Reference Brands: Volix®, Vocarb®, Voglimet®, Basen®(EU/Asia)

Category: Diabetes

Voglibose works by inhibiting intestinal alpha-glucosidase enzymes, delaying carbohydrate digestion and glucose absorption. This helps control post-meal blood sugar spikes. It is particularly beneficial for managing postprandial hyperglycemia in type 2 diabetes, improving glycemic control without causing significant hypoglycemia when used as monotherapy.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Voglibose is an oral alpha-glucosidase inhibitor used primarily for the management of postprandial blood glucose levels in type 2 diabetes mellitus. It is not FDA-approved in the United States and thus not commercially available there. In the European Union, Voglibose is not broadly authorized but may be marketed in specific regions under national licenses. The drug is extensively approved and utilized in countries like India and Japan, where it is sold under various brand names. It is often used alone or in combination with other antidiabetic agents. Regulatory approvals focus on its efficacy in delaying glucose absorption.

Voglibose Tablets — third party manufacturing & bulk supply

Voglibose Tablets 0.2 mg, 0.3 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Voglibose Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Voglibose Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Voglibose Tablets →

Back to Listing

Frequently Asked Questions

Voglibose Tablets is listed as Tablets in 0.2 mg, 0.3 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Voglibose Tablets is referenced against Volix®, Vocarb®, Voglimet®, Basen®(EU/Asia). Reference brands are shown for identification only and remain the property of their respective trademark owners.